SBRT achieved a 5-year DFS rate of 89% vs 92% with moderately hypofractionated IMRT in patients with intermediate-risk prostate cancer. Stereotactic body radiation therapy (SBRT) reduced rectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results